Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome
Clinical trial NCT01872182 · TERMINATED
Trial details
- NCT number
- NCT01872182
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-01-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.